Funding research to help us live longer
Gerald Averback of Saskatoon wants to help people live longer. His interest is research. Specifically, gene therapy research at the world-leading Mazankowski Alberta Heart Institute’s ABACUS Research Centre.
Through his company, Developments West Corporation, Mr. Averback made an incredible donation to create the $2 million Gerald Averback Medical Research Fund.
Mr. Averback chose to support the Maz after conducting thorough, Canada-wide research of his own. An alumnus of the University of Alberta, he searched the country for the research facility best-suited to his interest, and his commitment to the community.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells, instead of using drugs or surgery.